502 related articles for article (PubMed ID: 19454819)
1. Aggressive multi-visceral pancreatic resections for locally advanced neuroendocrine tumours. Is it worth it?
Abu Hilal M; McPhail MJ; Zeidan BA; Jones CE; Johnson CD; Pearce NW
JOP; 2009 May; 10(3):276-9. PubMed ID: 19454819
[TBL] [Abstract][Full Text] [Related]
2. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
3. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
Kazanjian KK; Reber HA; Hines OJ
Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
[TBL] [Abstract][Full Text] [Related]
4. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
5. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
[TBL] [Abstract][Full Text] [Related]
6. Extended surgery for advanced pancreatic endocrine tumours.
Kleine M; Schrem H; Vondran FW; Krech T; Klempnauer J; Bektas H
Br J Surg; 2012 Jan; 99(1):88-94. PubMed ID: 22135173
[TBL] [Abstract][Full Text] [Related]
7. Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?
Teh SH; Deveney C; Sheppard BC
Am J Surg; 2007 May; 193(5):610-3; discussion 613. PubMed ID: 17434366
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery in advanced endocrine tumours of the pancreas.
Pederzoli P; Falconi M; Bonora A; Salvia R; Sartori N; Contro C; Marcucci S; Bassi C
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S207-12. PubMed ID: 10604132
[TBL] [Abstract][Full Text] [Related]
10. [Risk and follow-up after multi-visceral resections including the left side of the pancreas].
Böttger T; Boddin J; Heintz A; Junginger T
Zentralbl Chir; 1995; 120(10):804-8. PubMed ID: 7502597
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
Shrikhande SV; Kleeff J; Reiser C; Weitz J; Hinz U; Esposito I; Schmidt J; Friess H; Büchler MW
Ann Surg Oncol; 2007 Jan; 14(1):118-27. PubMed ID: 17066229
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic resection for locally advanced primary and metastatic nonpancreatic neoplasms.
Pingpank JF; Hoffman JP; Sigurdson ER; Ross E; Sasson AR; Eisenberg BL
Am Surg; 2002 Apr; 68(4):337-40; discussion 340-1. PubMed ID: 11952243
[TBL] [Abstract][Full Text] [Related]
13. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
[TBL] [Abstract][Full Text] [Related]
14. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.
van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ
Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088
[TBL] [Abstract][Full Text] [Related]
15. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head.
Leach SD; Lee JE; Charnsangavej C; Cleary KR; Lowy AM; Fenoglio CJ; Pisters PW; Evans DB
Br J Surg; 1998 May; 85(5):611-7. PubMed ID: 9635805
[TBL] [Abstract][Full Text] [Related]
16. Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes.
Martin RC; Scoggins CR; Egnatashvili V; Staley CA; McMasters KM; Kooby DA
Arch Surg; 2009 Feb; 144(2):154-9. PubMed ID: 19221327
[TBL] [Abstract][Full Text] [Related]
17. Bypass surgery versus palliative pancreaticoduodenectomy in patients with advanced ductal adenocarcinoma of the pancreatic head, with an emphasis on quality of life analyses.
Schniewind B; Bestmann B; Kurdow R; Tepel J; Henne-Bruns D; Faendrich F; Kremer B; Kuechler T
Ann Surg Oncol; 2006 Nov; 13(11):1403-11. PubMed ID: 17009141
[TBL] [Abstract][Full Text] [Related]
18. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].
Fendrich V; Habbe N; Celik I; Langer P; Zielke A; Bartsch DK; Rothmund M
Dtsch Med Wochenschr; 2007 Feb; 132(5):195-200. PubMed ID: 17252361
[TBL] [Abstract][Full Text] [Related]
19. Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care.
Smoot RL; Zhang L; Sebo TJ; Que FG
J Am Coll Surg; 2008 Sep; 207(3):368-70. PubMed ID: 18722942
[TBL] [Abstract][Full Text] [Related]
20. Resection for cure of carcinoma of the colon directly invading the duodenum or pancreatic head.
Curley SA; Evans DB; Ames FC
J Am Coll Surg; 1994 Nov; 179(5):587-92. PubMed ID: 7952464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]